SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 28, 2022February 25, 2023

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 0-5109

 

MICROPAC INDUSTRIES, INC.

 

Delaware 75-1225149
(State or other jurisdiction of incorporation or organization)Incorporation) (I.R.S.IRS Employer Identification No.)
   

905 E. Walnut, Garland, Texas

 75040
(Address of Principal Executive Offices)Office) (Zip Code)

 

Registrant’s Telephone Number, including Area Code: (972) 272-3571

 

Securities Registered Pursuant to Section 12(g)12(b) of the Act:

 

Title of each classTrading
Symbol(s)
Name of each exchange on which registered
Common Stock, $0.10 par value per shareMPADNONE

 

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of large accelerated filer,” accelerated filer,” smaller reporting company,” and emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated fileroEmerging growth company     o

Accelerated filer

Non-accelerated filer

o

Smaller reporting company     x

Non-accelerated filero

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨No  x

On July 12, 2022,April 11, 2023 there were 2,578,315 shares of Common Stock, $0.10 par value, outstanding.

 

1 

 

MICROPAC INDUSTRIES, INC.

 

FORM 10-Q

 

May 28, 2022February 25, 2023

 

INDEX

 

PART I - FINANCIAL INFORMATION

ITEM 1 - FINANCIAL STATEMENTS

Condensed Balance Sheets as of May 28, 2022 (unaudited) and November 30, 2021

Condensed Statements of Operations for the three and six months ended May 28, 2022 and May 29, 2021 (unaudited)

Condensed Statements of Cash Flows for the six months ended May 28, 2022 and May 29, 2021 (unaudited)

Condensed Statements of Shareholders’ Equity for the three and six months ended May 28, 2022 and May 29, 2021 (unaudited)

Notes to Condensed Financial Statements (unaudited)

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 4 - CONTROLS AND PROCEDURES

PART II - OTHER INFORMATION

ITEM 1 - LEGAL PROCEEDINGS

ITEM 1A -RISK FACTORS

ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

ITEM 3 - DEFAULTS UPON SENIOR SECURITIES

ITEM 4 - MINE SAFETY DISCLOSURE

ITEM 5 - OTHER INFORMATION

ITEM 6 - EXHIBITS

SIGNATURES

PART I - FINANCIAL INFORMATION
ITEM 1 - FINANCIAL STATEMENTS3
Condensed Balance Sheets as of February 25, 2023 (unaudited) and November 30, 20223
Condensed Statements of Operations for the three months ended February 25, 2023 and February 26, 2022 (unaudited)4
Condensed Statements of Cash Flows for the three months ended February 25, 2023 and February 26, 2022 (unaudited)5
Statements of Shareholders’ Equity for the three months ended February 25, 2023 and February 26, 2022 (unaudited)6
Notes to Condensed Financial Statements (unaudited)7
ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS    13
ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK16
ITEM 4 - CONTROLS AND PROCEDURES16
PART II - OTHER INFORMATION
ITEM 1 - LEGAL PROCEEDINGS16
ITEM 1A -RISK FACTORS16
ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS16
ITEM 3 - DEFAULTS UPON SENIOR SECURITIES16
ITEM 4 - MINE SAFETY DISCLOSURE16
ITEM 5 - OTHER INFORMATION16
ITEM 6 - EXHIBITS16
SIGNATURES17

 

2 

 

PART I - FINANCIAL INFORMATION

ITEM 1.FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS

MICROPAC INDUSTRIES, INC.

CONDENSED BALANCE SHEETS

(Dollars in thousands)

  May 28, 2022 November 30, 2021
  (Unaudited)  
     
CURRENT ASSETS        
Cash and cash equivalents $16,019  $15,252 
Receivables, net of allowance for doubtful accounts of
$0 at May 28, 2022 and November 30, 2021
  3,755   4,974 
Contract assets  725   603 
Inventories:        
       Raw materials and supplies  6,351   5,738 
       Work in process  2,291   2,946 
                             Total inventories  8,642   8,684 
Prepaid expenses and other assets  421   341 
                             Total current assets  29,562   29,854 
         
PROPERTY, PLANT AND EQUIPMENT, at cost:        
Land  1,518   1,518 
Buildings  498   498 
Facility improvements  1,126   1,126 
Furniture and fixtures  1,036   1,025 
Construction in process  16,116   8,019 
Machinery and equipment  9,734   9,390 
                            Total property, plant, and equipment  30,028   21,576 
                            Less accumulated depreciation  (10,886)  (10,739)
                            Net property, plant, and equipment  19,142   10,837 
Operating lease right to use asset  41   67 
                            Total assets $48,745  $40,758 
         
LIABILITIES AND SHAREHOLDERS’ EQUITY        
         
CURRENT LIABILITIES:        
Accounts payable $1,603  $1,963 
Accrued compensation  1,025   1,295 
Deferred revenue  1,174   1,258 
Property taxes  189   318 
Income tax payable  95   180 
Operating lease liabilities, current portion  41   53 
Other accrued liabilities  25   25 
                               Total current liabilities  4,152   5,092 
         
Operating lease liabilities, less current portion       14 
Long Term Debt, net of debt issuance costs  11,613   3,369 
Deferred income taxes, net  16   16 
                               Total liabilities  15,781   8,491 
Commitments and contingencies        
         
SHAREHOLDERS’ EQUITY        
Common stock, $.10 par value, authorized
10,000,000 shares, 3,078,315 issued and
2,578,315 outstanding at May 28, 2022 and
November 30, 2021
  308   308 
Additional paid-in-capital  885   885 
Treasury stock, 500,000 shares, at cost  (1,250)  (1,250)
Retained earnings  33,021   32,324 
                               Total shareholders’ equity  32,964   32,267 
                               Total liabilities and shareholders’ equity $48,745  $40,758 
         

       
CURRENT ASSETS February 25, 2023  November 30, 2022 
  (Unaudited)    
       
Cash and cash equivalents $13,244  $15,375 
Receivables, net of allowance for doubtful accounts of $0 at February 25, 2023 and November 30 2022  2,810   3,644 
Other receivable  920   920 
Contract assets  722   408 
Inventories:        
Raw materials and supplies  7,164   6,715 
Work in process  4,175   3,573 
Total inventories  11,339   10,288 
Prepaid expenses and other assets  593   564 
Total current assets  29,629   31,199 
         
PROPERTY, PLANT AND EQUIPMENT, at cost:        
Land  1,518   1,518 
Buildings  498   498 
Facility improvements  1,126   1,126 
Furniture and fixtures  1,183   1,036 
Construction in process equipment  19,575   19,415 
Machinery and equipment  10,024   9,952 
Total property, plant, and equipment  33,924   33,545 
Less accumulated depreciation  (11,160)  (11,082)
Net property, plant, and equipment  22,764   22,463 
Operating lease right to use asset  -   14 
Deferred income taxes, net  86   86 
Total assets $52,479  $53,762 
         
LIABILITIES AND SHAREHOLDERS’ EQUITY        
         
CURRENT LIABILITIES:        
Accounts payable $1,469  $1,173 
Accrued compensation  842   1,086 
Deferred revenue  646   1,192 
Property taxes  131   560 
Income tax  25   149 
Current portion of long term debt  225   224 
Other accrued liabilities  25   47 
Total current liabilities  3,363   4,431 
         
Long term debt, net of debt issuance costs and current portion  14,634   14,535 
Total liabilities  17,997   18,966 
Commitments and contingencies        
         
SHAREHOLDERS’ EQUITY        
Common stock, $.10 par value, authorized   10,000,000 shares, 3,078,315 issued and 2,578,315 outstanding at February 25, 2023 and November 30 2022  308   308 
Additional paid-in-capital  885   885 
Treasury stock, 500,000 shares, at cost  (1,250)  (1,250)
Retained earnings  34,539   34,853 
Total shareholders’ equity  34,482   34,796 
Total liabilities and shareholders’ equity $52,479  $53,762 

 

See accompanying notes to financial statements.

3 

 

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Dollars in thousands except share data)

(Unaudited)

 

            
      Three Months ended   Six Months Ended        
 May 28, 2022 May 29, 2021 May 28, 2022 May 29, 2021 Three months ended 
         February 25, 2023 February 26, 2022 
             
NET SALES $7,188  $7,635  $13,254  $11,685  $6,190  $6,066 
                        
COST AND EXPENSES:                        
                        
Cost of goods sold  (4,245)  (4,141)  (7,521)  (6,831)  (3,939)  (3,276)
                        
Research and development  (502)  (398)  (966)  (743)  (652)  (464)
                        
Selling, general and administrative expenses  (1,850)  (1,590)  (3,618)  (2,979)  (1,806)  (1,768)
                        
Total cost and expenses  (6,597)  (6,129)  (12,105)  (10,553)  (6,397)  (5,508)
                        
OPERATING INCOME  591   1,506   1,149   1,132 
OPERATING INCOME (LOSS)  (207)  558 
                        
Other income (expense), net  1   (3)  2   21 
Other income, net  139   1 
                        
INCOME BEFORE TAXES  592   1,503   1,151   1,153 
INCOME (LOSS) BEFORE TAXES  (68)  559 
                        
Provision for taxes  101   210   196   161 
(Provision) benefit for taxes  12   (95)
                        
NET INCOME $491  $1,293  $955  $992 
NET INCOME PER SHARE, BASIC AND DILUTED $0.19  $0.50  $0.37  $0.38 
NET INCOME (LOSS) $(56) $464 
        
NET INCOME (LOSS) PER SHARE, BASIC AND DILUTED $(0.02) $0.18 
                        
DIVIDENDS PER SHARE $    $    $0.10  $0.10  $0.10  $0.10 
                        
WEIGHTED AVERAGE OF SHARES, basic and diluted  2,578,315   2,578,315   2,578,315   2,578,315   2,578,315   2,578,315 
                

 

See accompanying notes to financial statements.

4 

 

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

           
 Six months ended Three months ended 
CASH FLOWS FROM OPERATING ACTIVITIES: February 25, 2023 February 26, 2022 
 May 28, 2022 May 29, 2021     
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $955  $992 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:        
Net income (loss) $(56) $464 
Adjustments to reconcile net income (loss) to        
net cash provided by (used in) operating activities:        
Depreciation  197   197   103   98 
Amortization of right-of-use assets  26   23   14   13 
Changes in certain current assets and liabilities:                
Decrease (increase) in accounts receivable  1,219   (1,080)
Decrease in accounts receivable  834   1,490 
Increase in contract assets  (122)  (394)  (314)  (189)
Decrease (increase) in inventories  43   (312)
Increase (decrease) in prepaid expenses  (80)  86 
Decrease in prepaid income taxes       223 
Increase in inventories  (1,051)  (168)
(Increase) decrease in prepaid expenses and other assets  (29)  61 
(Decrease) increase in deferred revenue  (84)  106   (546)  181 
(Decrease) increase in accounts payable  (18)  8 
Increase (decrease) in accounts payable  372   (8)
Decrease in accrued compensation  (270)  (92)  (244)  (451)
Decrease in income tax payable  (85)  (85)
Decrease in income taxes payable  (124)  (42)
Decrease in lease liabilities  (26)  (23)  (14)  (13)
(Decrease) increase in all other accrued liabilities  (129)  13 
Decrease in all other accrued liabilities  (438)  (260)
                
Net cash provided by (used in) operating activities  1,626   (338)  (1,493)  1,176 
                
CASH FLOWS FROM INVESTING ACTIVITIES                
        
Additions to property, plant and equipment  (8,845)  (970)  (480)  (5,281)
                
Net cash used in investing activities  (8,845)  (970)  (480)  (5,281)
                
CASH FLOWS FROM FINANCING ACTIVITIES                
Cash dividend  (258)  (258)  (258)  (258)
Proceeds from long term debt  8,244        100   5,014 
                
Net cash provided by (used in) financing activities  7,986   (258)  (158)  4,756 
                
Net increase (decrease) in cash and cash equivalents  767   (1,566)  (2,131)  651 
                
Cash and cash equivalents at beginning of period  15,252   14,619   15,375   15,252 
                
Cash and cash equivalents at end of period $16,019  $13,053  $13,244  $15,903 
                
Supplemental Cash Flow Disclosure:                
Cash paid for income taxes $257  $24  $118  $137 
Supplemental Non-Cash Flow Disclosure:                
Changes in accrued property, plant, and equipment $879  $414 
        
Changes in accrued property, plant and equipment $75  $(269)

 

See accompanying notes to financial statements.

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF SHAREHOLDERS’ EQUITY

FOR THE QUARTERS ENDED MAY 28, 2022 AND MAY 29, 2021

(Dollars in thousands)

(Unaudited)

  Common Additional Treasury Retained  
  Stock paid-in-capital Stock Earnings Total
BALANCE, November 30, 2020 $308  $885  $(1,250) $29,524  $29,467 
                     
Dividend  0     0     0     (258)  (258)
Net loss  0     0     0     (301)  (301)
                     
BALANCE, February 27, 2021 $308  $885  $(1,250) $28,965  $28,908 
                     
Net income  0     0     0     1,293   1,293 
                     
BALANCE, May 29, 2021 $308  $885  $(1,250) $30,258  $30,201 
                     
   Common   Additional   Treasury   Retained     
   Stock      paid-in-capital   Stock   Earnings     Total    
BALANCE, November 30, 2021 $308  $885  $(1,250) $32,324  $32,267 
                     
Dividend  0     0     0     (258)  (258)
Net income  0     0     0     464   464 
                     
BALANCE, February 26, 2022 $308  $885  $(1,250) $32,530  $32,473 
                     
Net income  0     0     0     491   491 
                     
BALANCE, May 28, 2022 $308  $885  $(1,250) $33,021  $32,964 
                     

See accompanying notes to financial statements.

 

65 

 

MICROPAC INDUSTRIES, INC.

STATEMENTS OF SHAREHOLDERS’ EQUITY

FOR THE QUARTERS ENDED FEBRUARY 25, 2023 AND FEBRUARY 26, 2022

(Dollars in thousands)

(Unaudited)

                     
  Common  Additional  Treasury  Retained    
  Stock  paid-in-capital  Stock  Earnings  Total 
                
BALANCE, November 30, 2021 $308  $885  $(1,250) $32,324  $32,267 
                     
                     
Dividend  -   -   -   (258)   (258)
Net income  -   -   -   464   464 
                     
BALANCE, February 26, 2022 $308  $885  $(1,250) $32,530  $32,473 
                     
                     
                     
   Common   Additional   Treasury   Retained     
   Stock   paid-in-capital   Stock   Earnings   Total 
                     
BALANCE, November 30, 2022 $308  $885  $(1,250) $34,853  $34,796 
                     
                     
Dividend  -   -   -   (258)   (258)
Net loss  -   -   -   (56)  (56)
                     
BALANCE, February 25, 2023 $308  $885  $(1,250) $34,539  $34,482 

See accompanying notes to financial statements.

6

MICROPAC INDUSTRIES, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

Note 1 BASIS OF PRESENTATION

 

Business Description

 

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space, medical and commercial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200o C) products.

 

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2015 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

 

The Company’s core technologytechnologies are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

 

The business of the Company was started in 1963 as a sole proprietorship. On March 3, 1969, the Company was incorporated under the name of “Micropac Industries, Inc.” in the state of Delaware. The stock was publicly held by 436435 shareholders on May 28, 2022.February 25, 2023.

 

In the opinion of management, the unaudited financial statements include all adjustments (consisting of only normal, recurring adjustments) necessary to present fairly the financial position as of May 28, 2022,February 25, 2023, the results of operations for the three and six months May 28, 2022 and May 29, 2021 ant the cash flows for the sixthree months ended May 28, 2022February 25, 2023 and May 29, 2021.February 26, 2022. Unaudited financial statements are prepared on a basis substantially consistent with those audited for the year ended November 30, 2021.2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (GAAP) have been condensed or omitted pursuant to the rules and regulations promulgated by the Securities and Exchange Commission. The Company’s fiscal year ends on the last day of November. The quarterly results end on the last Saturday of the quarter.

 

It is suggested that these financial statements be read in conjunction with the November 30, 20212022 Form 10-K filed with the SEC, including the audited financial statements and the accompanying notes thereto.

 

Note 2 SIGNIFICANT ACCOUNTING POLICIES

 

Revenue Recognition

 

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

 

The Company's revenue on the majority of its customer contracts areis recognized at a point in time, generally upon shipment of products.

 

To achieve that core principle, the Company applies the following steps:

 

1.Identify the contract(s) with a customer.

1. Identify the contract(s) with a customer.

 

The Company designs, manufactures and distributes various types of microelectronic circuits, optoelectronics, and sensors and displays. The Company’s products are used as components and assemblies in a broad range of military, space, medical and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200o C) products.

 

The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

 

2.7
Identify the performance obligations in the contract.

2.  Identify the performance obligations in the contract.

 

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

 

3.Determine the transaction price.

3. Determine the transaction price.

 

The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss.

 

4.Allocate the transaction price to the performance obligations in the contract.

4.  Allocate the transaction price to the performance obligations in the contract.

 

The Company’s transaction price is the fixed price per unit per each delivery upon shipment.

 

5.Recognize revenue when (or as) the Company satisfies a performance obligation.

5.  Recognize revenue when (or as) the Company satisfies a performance obligation.

 

This performance obligation is satisfied when control of the product is transferred to the customer, which occurs upon shipment or delivery. The Company receives purchase orders for products to be delivered over multiple dates that may extend across reporting periods. The Company accounting policy treats shipping and handling activities as a fulfillment cost. The Company invoices for each delivery upon shipment and recognizes revenues at the fixed price for each distinct product delivered when transfer of control has occurred, which is generally upon shipment.

 

For certain contracts under which the Company produces products with no alternative use and for which the Company has an enforceable right to payment during the production cycle, the Company recognizes revenue for the cost incurred of work in process plus a margin at the end of each period and records a contract asset (unbilled receivable). The majority of these products are shipped weekly and monthly to the customers and the contracts require us to manage and limit the level of work in process to meet the scheduled delivery dates.

 

In addition, the Company may have a contract or purchase order to provide a non-recurring engineering service to a customer. These contracts are reviewed, and performance obligations are determined and we recognize revenue at the point in time in which each performance obligation is fully satisfied.

 

Disaggregation of Revenue

The following table summarizes the Company’s Net Salesnet sales by Product Line.product line.

   5/28/2022  5/29/2021
Microcircuits $3,400 $2,741
Optoeletronics  4,235  3,774
Sensors and Displays  5,619  5,170
    Total Revenue $13,254 $11,685
       
Timing of revenue recognition      
Transferred at a point in time $11,429 $9,770
Transferred over time  1,825  1,915
    Total Revenue $13,254 $11,685

Schedule of net sales by product line        
  Net Sales by Product Line 
  (Dollars in thousands) 
    
  Feb. 25, 2023  Feb. 26, 2022 
Microelectronics $1,020  $1,541 
Optoelectronics  1,857   2,205 
Sensors and Displays  3,313   2,320 
  $6,190  $6,066 
Timing of revenue recognition:        
Recognized at a point in time $5,112  $5,351 
Recognized over time  1,078   715 
Total Revenue $6,190  $6,066 

The following table summarizes the Company’s Net Salesnet sales by Major Market.major market.

                     

2022 Second Quarter Sales by Major Market

  Military Space Medical Commercial Total
Domestic Direct $3,134  $196  $830  $344  $4,504 
Domestic Distribution  1,591   572   0   334   2,497 
International       127   0   60   187 
  $4,725  $895  $830  $738  $7,188 
                     
2021 Second Quarter Sales by Major Market
    Military    Space    Medical    Commercial    Total 
Domestic Direct $2,588  $951  $1,158  $139  $4,836 
Domestic Distribution  2,308   172   0   178   2,658 
International  64   9   0   68   141 
  $4,960  $1,132  $1,158  $385  $7,635 
                     
 2022 Six Months Sales by Major Market
    Military    Space    Medical    Commercial    Total 
Domestic Direct $5,638  $799  $1,384  $534  $8,355 
Domestic Distribution  3,384   718   0     473   4,575 
International  71   150   0     103   324 
  $9,093  $1,667  $1,384  $1,110  $13,254 
                     
  2021 Six Months Sales by Major Market
    Military    Space    Medical    Commercial    Total 
Domestic Direct $4,011  $1,170  $1,708  $287  $7,176 
Domestic Distribution  3,335   536   0     297   4,168 
International  127   136   0     78   341 
  $7,473  $1,842  $1,708  $662  $11,685 

Schedule of net sales by major market                    

2023 First Quarter Sales by Major Market

(Dollars in thousands)

  Military  Space  Medical  Commercial  Total 
Domestic Direct $1,310  $52  $950  $1,306  $3,618 
Domestic Distribution  1,736   410   -   150   2,296 
International  28   2   -   246   276 
  $3,074  $464  $950  $1,702  $6,190 

 

8

2022 First Quarter Sales by Major Market
(Dollars in thousands)

   Military   Space   Medical   Commercial   Total
Domestic Direct $2,505  $603  $555  $189  $3,852 
Domestic Distribution  1,793   146   -   139   2,078 
International  71   22   -   43   136 
  $4,369  $771  $555  $371  $6,066 

Receivables, net, Contract Assets and Contract Liabilities

 

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (deferred revenue) on the Condensed Balance Sheet.Sheets. 

 

Receivables, net, contract assets and contract liabilities were as follows:

 

Receivables, net, Contract Assets and Contract Liabilities

(Dollars in thousands)

 

Schedule of receivables, net, contract assets and contract liabilities            
May 28, 2022 November 30, 2021 December 1, 2020 February 25, 2023 November 30, 2022 December 1, 2021 
Receivables, net$3,755  $4,974  $2,639  $2,810  $3,644  $4,974 
Contract assets$725  $603  $512  $722  $408  $603 
Deferred revenue$1,174  $1,258  $111  $646  $1,192  $1,258 

 

There was $103,000546,000 of revenue recognized in fiscal year 20222023 that was included in the deferred revenue liability balance at the beginning of the fiscal year.

 

Contract costs

 

The Company does not have material incremental costs to obtain a contract in the form of sales commissions or bonuses. The Company incurs other immaterial costs to obtain and fulfill a contract; however, the Company has elected the practical expedient under ASC 340-40-24-4 to recognize all incremental costs to obtain a contract as an expense when incurred if the amortization period is one year or less.

 

Leases

 

In the first quarter of 2020, the Company entered into a three (3) year lease extension on the property that has been leased on a year to year basis. As a result, we recognized $165,000 for operating lease liabilities and right-of-use assets in accordance with ASC 842. The Company had an operating lease expense of $26,00014,000 for the first sixthree months of 20222023 and $26,00013,000 for the first sixthree months of 2021.2022. The Company used an estimated incremental borrowing rate of 3.25% representative of the rate of interest that the company would have to pay to borrow on the Company’s line of credit. The remaining lease term is three years.

The Undiscounted Future Minimum Lease Payments consist of the following at:

   5/28/2022 
2022  $28,000 
2023   14,000 
Total lease payments   42,000 
Interest   1,000 
Present value of lease liabilities  $41,000 
      

Short-Term Investmentsmonth to month.

 

The Company had 0Inventories short-term investments at May 28, 2022 or November 30, 2021. Short-term investments consist of certificates of deposits with maturities greater than 90 days. These investments are reported at historical cost, which approximates fair value. All highly liquid investments with maturities of 90 days or less are classified as cash equivalents.

Inventories

 

Inventories are stated at lower of cost or net realizable value and include material, labor and manufacturing overhead. All inventories are valued using the FIFO (first-in, first-out) method of inventory valuation. The Company determines the need to write inventory down to the lower of cost or net realizable value via an analysis based on the usage of inventory over a three year period and projected usage based on current backlog.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method. Under this method the Company records deferred income taxes for the temporary differences between the financial reporting basis and the tax basis of assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. The resulting deferred tax liabilities and assets are adjusted to reflect changes in tax law or rates in the period that includes the enactment date.

 

The Company records a liability for an unrecognized tax benefit for a tax position that is notnot “more-likely-than-not” to be sustained.  The Company did not record any liability for uncertain tax positions as of May 28, 2022February 25, 2023 or November 30, 2021.2022.

 

9

Property, Plant, and Equipment

 

Property, plant, and equipment are carried at cost, and depreciation is provided using the straight-line method at rates based upon the following estimated useful lives (in years) of the assets:

    
Buildings.........................................................................................................................................................1530
Facility improvements.........................................................................................................................................................815
Machinery and equipment.........................................................................................................................................................510
Furniture and fixtures.........................................................................................................................................................58
Schedule of property,plant and equipment useful lives
Buildings15-30
Facility improvements8-15
Machinery and equipment5-10
Furniture and fixtures5-8

 

The Company assesses long-lived assets for impairment in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) ASC 360-10-35, Property, Plant and Equipment – Subsequent Measurement. When events or circumstances indicate that an asset may be impaired, an assessment is performed. The estimated future undiscounted cash flows associated with the asset are compared to the asset’s net book value to determine if a write down to market value less cost to sell is required.

 

Construction in progress relates to multiple capital projects ongoing during the yearsyear ended November 30, 20212022 and the sixthree months ended May 28, 2022,February 25, 2023, including the construction of the new manufacturing facility. Construction in progress also includes interest and fees on debt that are directly related to the financing of the Company’s capital projects.

 

Repairs and maintenance are expensed as incurred. Improvements which extend the useful lives of property, plant, and equipment are capitalized.

 

Research and Development Costs

 

Costs for the design and development of new products are expensed as incurred.

 

Basic and Diluted Earnings Per Share

 

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common

10 

shares. For the three months ended February 25, 2023 and six months ended May 28,February 26, 2022, and May 29, 2021, the Company had 0no dilutive potential common stock instruments.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Note 3 NEW ACCOUNTING PRONOUNCEMENTS

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which changes the impairment model for most financial assets. The ASU requires the use of an “expected loss” model for instruments measured at amortized cost, in which companies will be required to estimate the lifetime expected credit loss and record an allowance to offset the amortized cost basis, resulting in a net presentation of the amount expected to be collected on the financial asset. The new guidance is effective for fiscal years beginning after December 15, 2022 for Smaller Reporting Companies, including interim periods within those fiscal years and requires a modified-retrospective approach to adoption. The Company believes that adopting ASU 2016-13 will have no material impact on the financial statements and related disclosures.

 

Note 4 FAIR VALUE MEASUREMENT

 

The Company had 0no financial assets or liabilities measured at fair value on a recurring basis as of May 28, 2022February 25, 2023 or November 30, 2021.2022.  The fair value of financial instruments such as cash and cash equivalents, accounts receivable, and accounts payable approximate their carrying amount based on the short maturity of these instruments.

 

The Company measures its long-term debt at fair value, which approximates book value as the long-term debt bears market rates of interestinterest.

 

There were 0no nonfinancial assets measured at fair value on a nonrecurring basis May 28, 2022February 25, 2023 and November 30, 2021.2022.

10

 

Note 5 COMMITMENTS

 

The Company obtained a commercial real estate construction loan for the construction of a new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas that the Company has purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement (the “loan agreement”) with Frost Bank (“Frost”) (acting as lender). The Construction Loan Agreement provides for a construction loan, in amounts not to exceed a total principal balance of $16,160,000 with an interest rate of (3.40%) per annum.

 

On March 26, 2021, the Company renewed the Revolving Loan Agreement with Frost through the “Sixth Amendment to Loan Agreement.”. The Revolving Loan Agreement provides for revolving credit loans, in amounts not to exceed a total principal balance of $6,000,000 with a rate equal to prime rate with a floor of 3.25%. The Revolving Loan Agreement was originally entered into on January 23, 2013, between the Company as borrower and Frost as lender.  

 

Construction Loans.  Subject to the terms of the Loan Agreement, Frost will lend to the Company an aggregate amount not to exceed $16,160,000.$16,160,000.

 

Principal and interest shall be due and payable monthly in an amounts determined by Lender required to fully amortize the outstanding principal balance of this Note over a period of twenty-five (25) years, payable on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2023, and continuing regularly thereafter until March 26, 2031, when the entire amount hereof, principal and accrued interest then remaining unpaid, shall be then due and payable; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

 

The interest rate of (3.40%(3.40%) per annum including an Interest-Only Period. Interest only shall be due and payable monthly as it accrues on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2021, and continuing regularly and monthly thereafter until March 26, 2023; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

11 

The loan shall be secured by a “Deed of Trust, Security Agreement – Financing Statement” covering the 9.2 acre tract in Garland, Texas and the improvements made on it.

 

Revolving Credit Loans.  Subject to the terms of the, Loan Agreement, Frost will lend to the Company, on a revolving basis, amounts not to exceed a total principal balance of $6,000,000,$6,000,000, minus amounts available and amounts previously disbursed under outstanding Frost letters of credit. Subject to certain terms and conditions, the Company may borrow, repay and reborrow under the Loan Agreement. The loan has a maturity date of April 23, 2023.

 

The interest on the outstanding and unpaid principal balance shall be computed at a per annum rate equal to the lesser of (a) a rate equal to the Prime Rate per annum; provided, however, in no event shall the resulting rate be less than three and one-quarter percent (3.25%).

 

The Company has borrowed $11,792,00015,010,000 against the construction loan as of May 28, 2022.February 25, 2023.

 

Debt  May 28, 2022 
Schedule of long-term debt   

Debt February 25, 2023

   
Notes payable $11,792,000  $15,010,000 
Less unamortized debt issuance costs  179,000   151,000 
Net Debt  11,613,000   14,859,000 
Less—Current portion  0     225,000 
Total long-term debt $11,613,000  $14,634,000 

Estimated maturities of our long-term debt over the next 5 years are as follows:

Schedule of maturities of long-term debt                     
  2023  2024  2025  2026  2027  Thereafter  Total 
Frost Bank $225  $396  $409  $423  $438  $13,119  $15,010 

 

Note 6 EARNINGS PER COMMON SHARE

 

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common shares. For the three months ended February 25, 2023 and six month periods ended May 28,February 26, 2022, and May 29, 2021, the Company had no dilutive potential common stock instruments.

11

 

Note 7 SHAREHOLDERS’ EQUITY

 

On December 8, 20207, 2022, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 6, 202111, 2023. The dividend was paid to shareholders on February 12, 202110, 2023.

 

On December 7, 2021, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 11, 2022. The dividend was paid to shareholders on February 10, 2022.

 

[The remainder of this page intentionally left blank.]

12 

 

MICROPAC INDUSTRIES, INC.

(Unaudited)

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Business

 

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200o C) products.

 

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2008 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier, and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

 

The Company’s core technology are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

 

Critical Accounting Policies

 

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We base our estimates on historical experience and on various other assumptions and factors that are believed to be reasonable under the circumstances. Note 2 to the Financial Statements in the Quarterly Report Form 10-Q for the quarter ended May 28, 2022,February 25, 2023, describes the significant accounting policies and methods used in the preparation of the Financial Statements. liabilities. Actual results could differ from these estimates.

 

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company’s revenue on the majority of its customer contracts are recognized at a point in time, generally upon shipment of products. The application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates. Specifically, the determination of whether revenues related to our revenue contracts should be recognized over time or at a point in time, as these determinations impact the timing and amount of our reported revenues and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to receive payment, as well as the progress of the job order to completion in order to determine the amount of consideration earned for contractual revenue recognized over time.

 

The allowance for doubtful accounts is based on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. If there is a deterioration of a major customer’s credit worthiness or actual defaults are higher than our historical experience, our estimates of the recoverability of amounts due us could be adversely affected.

 

Inventory purchases and commitments are based upon future demand. If there is a sudden and significant decrease in demand for our products or there is a higher risk of inventory obsolescence because of changing customer requirements, we may be required to increase our inventory allowances and our gross margin could be adversely affected.

 

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. If we were to determine we would not be able to realize all or part of the deferred tax asset in the future, an adjustment to the deferred tax asset would be necessary which would reduce our net income for that period.

 

13

Depreciable and useful lives estimated for property and equipment are based on initial expectations of the period of time these assets will provide benefit. Changes in circumstances related to a change in our business

13 

or other factors could result in these assets becoming impaired, which could adversely affect the value of these assets.

 

Results of Operations

      Three months ended Six months ended
   5/28/2022   5/29/2021   5/28/2022   5/29/2021 
NET SALES  100.0%  100.0%  100.0%  100.0%
                 
COST AND EXPENSES:                
    Cost of Goods Sold  59.1%  54.3%  56.7%  58.4%
    Research and development  7.0%  5.2%  7.3%  6.4%
    Selling, general and administrative expenses  25.7%  20.8%  27.3%  25.5%
                                    Total cost and expenses  91.8%  80.3%  91.3%  90.3%
                 
OPERATING INCOME BEFORE INTEREST  8.2%  19.7%  8.7%  9.7%
           AND INCOME TAXES                
                 
    Interest and other income, net  —     —     —     0.2%
                 
INCOME BEFORE TAXES  8.2%  19.7%  8.7%  9.9%
                 
    Provision for taxes  1.4%  2.8%  1.5%  1.4%
                 
NET INCOME  6.8%  16.9%  7.2%  8.5%

  Three months ended 
  February 25, 2023  February 26,2022 
NET SALES  100.0%   100.0% 
         
COST AND EXPENSES:        
Cost of Goods Sold  63.6%   54.0% 
Research and development  10.5%   7.6% 
Selling, general & administrative expenses  29.2%   29.1% 
Total cost and expenses  103.3%   90.7% 
         
OPERATING INCOME (LOSS)  (3.3)%  9.3% 
         
Other income, net  2.2%   0.0% 
         
INCOME (LOSS) BEFORE TAXES  (1.1)%  9.2% 
         
(Provision) benefit for taxes  .2%   (1.6)%
         
INCOME (LOSS)  (0.9)%  7.7% 

 

Sales for the three and six month periodsfirst quarter ended May 28, 2022February 25, 2023, totaled $7,188,000 and $13,254,000, respectively.$6,190,000. Sales for the secondfirst quarter decreased $447,000 from the same periodincreased 2% or $124,000 above sales of 2021 while sales$6,066,000 for the first six monthsquarter of 2022 increased $1,569,000 from the first six months of 2021. The majority of the increase is related to timing of shipments of customer orders of standard microelectronic products. Sales were 8% in the commercial market, 10% in the medical market, 69% in the military market, and 13% in the space market for the six months ended May 28, 2022 compared to 6% in the commercial market, 14% in the medical market, 64% in the military market, and 16% in the space market for the six months ended May 29, 2021.

 

TwoThree customers accounted for 15%, 11% and 11%10% of the Company’s sales for the first quarter of 2023 and three months ended May 28, 2022, and one customercustomers accounted for 17% for the six months ended May 28, 2022, while one customer accounted for 20%18% and 19%11%, and 10% of the Company’s sales for the first quarter of 2022. The three months and six months ended May 29, 2021.customers are distributors that sell to multiple customers.

 

Cost of goods sold for the second quartersfirst quarter of 2023 and 2022 totaled 63.6% and 2021 totaled 59.1% and 54.3% of net sales, respectively, while cost of goods sold for the six months ended May 28, 2022 and May 29, 2021 totaled 56.7% and 58.4%54.0% of net sales, respectively. In actual dollars, costCost of goods soldsales increased $104,000 in$662,000 or 20% for the secondfirst quarter of 20222023 as compared to the first quarter of 2022.Two new custom products for separate customers have incurred higher material cost during the engineering and first production builds resulting in lower gross margins.

Research and development cost increased $188,000 for the first quarter of 2023 compared to the same period of 2021. Year to date cost2022. The research and development expenditures were associated with the continued development of goods sold increased $690,000power management products, sensor products and process automation improvements.

Selling, general and administrative expenses for the first six monthsquarter of 20222023 totaled 29.2% of net sales, compared to 29.1% for the same period in 2022. Selling, general and administrative expenses increased $39,000 in the first quarter of 2023 as compared to 2022.

Provisions for taxes decreased $107,000 for the first quarter of 2023 compared to the same period in 2021.2022. The majorityestimated effective tax rate was 17% for the first quarter of the increase2023 and 2022. The decrease was related to a net loss in the secondcurrent period compared to a net profit in the 2022 period.

The Company had a net loss in the first quarter isof 2023 of $56,000 compared to a net profit of $464,000 in the first quarter of 2022 associated with the increase in cost of goods sold with the decrease in sales compared to second quarter of 2021.

Research and development expense increased $104,000 for the second quarter of 2022 versus 2021 and increased $223,000 for the first six months of 2022 compared to the same period of 2021. The research and development expenditures were associated with continued development of several power management products, fiber optic transceivers and high voltage optocouplers. The Company will continue to invest in research and development of these products and other new opportunities.

Selling, general and administrative expenses for the second quarter and first six months of 2022 totaled 25.7% and 27.3% respectively of net sales compared to 20.8% and 25.5% for the same periods in 2021. In actual dollars, selling, general and administrative expenses increased $260,000 for the second quarter and increased $639,000 for the first six months of 2022 compared to the same periods in 2021. The majority of the increase for the first six months resulted from an increase in commission expense in 2022, property tax on the new building and consultant fees.

14 

Provisions for taxes decreased $109,000 for the second quarter of 2022 and increased $35,000 for the first six months of 2022 compared to the same period in 2021. The estimated effective tax rate was 17% for 2022 and 14% for 2021.

Net income decreased $802,000 for the second quarter of 2022 versus 2021 and decreased $36,000 for the first six months of 2022 compared to the same period of 2021.2022.

 

Liquidity and Capital Resources

 

The Company will use a combination of cash and a commercial real estate construction loan for the construction of a new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas the Company purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement with Frost Bank (“Frost”), (acting as lender). The Construction Loan Agreement provides for a construction loan as discussed in Note 5 to the condensed financial statements.

 

14

As of May 28, 2022,February 25, 2023, the Company has $16,116,000$17,525,000 in construction in process on the new facility and has $11,792,000$15,010,000 in notes payable on the construction loan, outstanding draw request of $879,000$140,000 in accounts payableaccount payables and has used $2,515,000$2,375,000 of the Company’s cash. In addition, the Company has unamortized loan fees on the construction loan in the amount of $179,000.$151,000.

In addition, the Company continues on-going investigations for the use of cumulative cash for business expansion and improvements, such as operational improvements and new product expansion.

 

Cash and cash equivalents totaled $16,019,000$13,244,000 as of May 28, 2022February 25, 2023 compared to $15,252,000$15,375,000 on November 30, 2021, an increase2022, a decrease of $767,000.$2,131,000. The increasedecrease in cash and cash equivalents is attributable to $1,626,000$1,493,000 cash provided byused in operations, $8,244,000$100,000 proceeds from the construction loan, offset by the payment of a cash dividend of $258,000, $356,000$320,000 in cash for additional manufacturing equipment and $8,489,000$160,000 for construction in process on the new facility.

 

In addition to cash on hand, the Company also has the ability to borrow under a loan agreement as discussed in Note 5 to the condensed financial statements.

 

The Company has no significant off-balance sheet arrangements.

 

Outlook

 

New orders for year-to-date 2022the first quarter of 2023 totaled $15,395,000$6,361,000 compared to $13,105,000$7,223,000 for 2021. The increase resulted from timingthe comparable period of new orders for several custom products.

2022. Backlog totaled $35,055,000$33,496,000 on May 28, 2022February 25, 2023 compared to $31,517,000$33,823,000 as of May 29, 2021February 26, 2022 and $32,635,000$32,686,000 on November 30, 2021 and represents a good mix2022. Approximately $24,305,000 of the company’s products and technologies.current backlog is expected to ship during the remainder of 2023.

 

2022 Current Backlog by Major Market

2023 Current Backlog by Major Market

(Dollars in thousands)

2023 Current Backlog by Major Market

(Dollars in thousands)

 Military Space Medical Commercial Total Military Space Medical Commercial Total 
Domestic Direct $17,937  $1,359  $4,263  $2,312  $25,871  $17,935  $1,678  $4,461  $2,007  $26,081 
Domestic Distribution  7,594   710   —     430   8,734   4,135   1,822   -   490  $6,447 
International  116   65   —     269   450   274   213   -   481  $968 
 $25,647  $2,134  $4,263  $3,011  $35,055  $22,344  $3,713  $4,461  $2,978  $33,496 

 

2022 Current Backlog by Product Line
Microelectronics $12,507 
Optoelectronics  5,639 
Sensors and Displays  16,909 
  $35,055 

2023 Current Backlog by Product Line

(Dollars in thousands)

Microelectronics $12,102 
Optoelectronics  5,677 
Sensors and Displays  15,717 
  $33,496 

 

The Company cannot assure that the results of operations for the interim period presented are indicative of total results for the entire year due to fluctuations in customer delivery schedules, or other factors over which the Company has no control.

 

Impact of COVID-19 on our Business

 

In March 2020 the World Health Organization declared the spread of the COVID-19 virus a pandemic.

15 

The Company continues to monitor our supply chain and orders from customers for COVID-19 pandemic related changes. We are continuing to serve our customers while taking precautions to provide a safe work environment for our employees and customers. We have been staggering some shifts and otherwise adjusting work schedules to maximize our capacity while adhering to recommended precautions. We have established and implemented a work from home provision where possible.

 

To date, we have not experienced significant raw material shortages; however, supply-chain disruptions could potentially delay or prevent us from fulfilling customer orders.

 

Cautionary Statement

 

This Form 10-Q contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially. Investors are warned that forward-looking statements involve risks and unknown factors including, but not limited to: our expectations regarding the potential impacts on our operations of the COVID-19 pandemic; our expectations regarding the potential impacts on our supply chain and on our customers of the COVID-19 pandemic; overall changes in governmental spending for military and space programs; customer cancellation or rescheduling of orders, problems affecting delivery of vendor-supplied raw materials and components, unanticipated manufacturing problems and availability of direct labor resources.

 

15

The Company does not intend to update the forward-looking statements contained herein, except as may be required by law.

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable

 

ITEM 4.CONTROLS AND PROCEDURES

 

(a)Evaluation of disclosure controls and procedures.

 

The Chief Executive Officer and Chief Financial Officer of the Company evaluated the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15) as of May 28, 2022February 25, 2023 and, based on this evaluation, concluded that the Company’s disclosure controls and procedures are functioning in an effective manner to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms.

 

(b)Changes in internal controls.

 

There has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting during the three monththree-month period ended May 28, 2022.

February 25, 2023.

 

PART II - OTHER INFORMATION

 

ITEM 1.LEGAL PROCEEDINGS

 

The Company is not involved in any material current or pending legal proceedings.

 

ITEM 1ARISK FACTORS

 

Information about risk factors for the three and six months ended May 28, 2022February 25, 2023 does not differ materially from that set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended November 30, 20212022.

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4.

MINE SAFETY DISCLOSURE

 

16 

Not Applicable

 

ITEM 5.

OTHER INFORMATION

 

None

 

ITEM 6.

EXHIBITS

 

(a)        Exhibits

 

31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

32.2

Certification of Chief Accounting Officer pursuant to 18 U. S. C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

 16 

 

SIGNATURES

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.

 

 

MICROPAC INDUSTRIES, INC.

 

 

July 12, 2022 /s/ Mark King
DateApril 11, 2023 
DateMark King
  Chief Executive Officer

July 12, 2022 /s/ Patrick Cefalu
DatePatrick Cefalu
  
/s/ Patrick Cefalu
April 11, 2023
DatePatrick Cefalu
Chief Financial Officer

17